Michael Martin Breen, Executive Chairman/Interim CEO, Director at GT Biopharma, holds 856.22K shares in GT Biopharma (Ticker: GTBP), holds 1.14M shares in Prairie Operating Co (Ticker: PROP).

See the Hottest Stocks Based on Insider Trading >

Michael Martin Breen
GT Biopharma (GTBP)
Executive Chairman/Interim CEO, Director

Ranked #8,536 out of 98,624 Corporate Insiders

Profitable Transactions

1 out of 3 Profitable Transactions

Average Return

+113.80%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

85.40%

PROP

14.60%

GTBP

A breakdown of Michael Martin Breen's holdings

See the Top Stocks by Insiders

Insider Roles

Prairie Operating Co
(PROP)

Director

GT Biopharma
(GTBP)

Executive Chairman/Interim CEO, Director

Roles that Michael Martin Breen holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Prairie Operating Co
(PROP)

Rating:Informative Buy

Date:May 05, 2023 - May 05, 2024

Return:+474.60%

The most profitable trade made by Michael Martin Breen

See the Latest Stocks Traded by Insiders

Michael Martin Breen's Trading History

GTBP

GT Biopharma

Aug 15, 2023

Executive Chairman/Interim CEO, Director

Uninformative Buy

56.00K

$2.83M

PROP

Prairie Operating Co

May 05, 2023

Director

Uninformative Buy

37.16K

$16.53M

List of latest transactions for each holding click on a transaction to see Michael Martin Breen's performance on stock

See All Insider Trading from Today

Michael Martin Breen insider profile FAQ

What is the percentage of profitable transactions made by Michael Martin Breen?

The percentage of profitable transactions made by Michael Martin Breen is 33%.

What is the average return per transaction made by Michael Martin Breen?

The average return per transaction made by Michael Martin Breen is 113.80%.

What stocks does Michael Martin Breen hold?

Michael Martin Breen holds: GTBP, PROP stocks.

What was Michael Martin Breen’s latest transaction?

Michael Martin Breen latest transaction was an Uninformative Buy of $56.00K.

What was Michael Martin Breen's most profitable transaction?

Michael Martin Breen’s most profitable transaction was an Informative Buy of PROP stock on May 5, 2023. The return on the trade was 474.60%.

What is Michael Martin Breen's role in GT Biopharma?

Michael Martin Breen's role in GT Biopharma is Executive Chairman/Interim CEO, Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Michael Martin Breen Insider Profile

Michael Martin Breen GT Biopharma (GTBP)Executive Chairman/Interim CEO, Director